Previous 10 |
HOUSTON , Dec. 10, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, received positive feedback from the U.S. Food and Drug Administration (FDA) for its...
HOUSTON , Dec. 9, 2019 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that John Climaco , Chief Executive Officer of CNS Pharmaceuticals,...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
18.56%Change Percent:
CNS Pharmaceuticals Inc. Company Name:
CNSP Stock Symbol:
NASDAQ Market:
CNS Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 7.0% to $103.73 on volume of 461,121,707 shares PROSHARES TRUST (SQQQ) rose 4.2% to $9.43 on volume of 197,353,222 shares Agape ATP Corporation (ATPC) rose 54.3% to $0.135 on volume of 196,014,250 shares ...
A look at the top 10 most actives in the United States Agape ATP Corporation (ATPC) rose 148.2% to $0.2172 on volume of 69,599,062 shares Imunon Inc. (IMNN) rose 154.6% to $3.03 on volume of 68,427,736 shares Jet.AI Inc. (JTAI) rose 27.2% to $0.380102 on volume of 41,454,602 shares SoFi T...
Strategic in-license from Cortice Bioscience is highly synergistic with the ongoing potentially pivotal Berubicin program and demonstrates further commitment to changing the treatment paradigm in GBM Drug candidate, TPI 287, awarded Orphan designation and studied in over 350 patients to date...